Immune checkpoint inhibitor plus anti-EGFR target therapy plus chemotherapy in patients with locally advanced penile squamous cell carcinoma.

Hui Han,Xin An,Ru Yan,Shengjie Guo,Cong Xue,Ting Yu Liu,Li Tian,Huali Ma,Yonghong Li,Zike Qin,Zhuowei Liu,Fangjian Zhou,Yanxia Shi

Immune checkpoint inhibitor plus anti-EGFR target therapy plus chemotherapy in patients with locally advanced penile squamous cell carcinoma.

2021

Hui Han
Xin An
Ru Yan
Shengjie Guo
Cong Xue
Ting Yu Liu
Li Tian
Huali Ma
Yonghong Li
Zike Qin
Zhuowei Liu
Fangjian Zhou
Yanxia Shi

e17016Background: Locally advanced penile squamous cell carcinomas (PSCCs) have poor prognosis and limited therapeutic options. We aim to evaluate the safety and the efficacy of neoadjuvant therapy...

Keywords:

in patient
locally advanced
Chemotherapy
Cell
Penile squamous cell carcinoma
Medicine
Oncology
Internal medicine
target therapy
Neoadjuvant therapy
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations